<DOC>
	<DOCNO>NCT00553553</DOCNO>
	<brief_summary>The patient population require hepatic resection demonstrate unpredictable risk exhibit peri-operative coagulopathy result either pre-operative hepatic pathophysiology volume parenchymal resection . Choice analgesia severely limited . Currently , commonly describe use combine remifentanil infusion intrathecal morphine fast-track cardiac surgery . To date , publish data describe use context major hepatobiliary investigator predict may provide adequate analgesia low rate adverse effect first 24 hour surgery .</brief_summary>
	<brief_title>Efficacy Multimodal Opioid Therapy During Hepatic Resection Surgery</brief_title>
	<detailed_description>Choice analgesia hepatic resection surgery severely limited . This depend upon pre-operative hepatic pathophysiology extent parenchymal resection , affect peri-operative hepatic function , capacity drug handle risk coagulopathy . Use IV morphine hepatic resection result high plasma level post-operatively due reduce rate morphine metabolism , risk high rate morbidity . However , remain mainstay peri-operative analgesia combination controversial non-opioid supplementation ( paracetamol , non-steroidal anti-inflammatory drug ) . This study compare efficacy IV morphine versus combination pre-incisional intrathecal morphine intra-operative IV remifentanil . Intrathecal morphine provide mainstay post-operative analgesia 12-24 hour remifentanil provide profound , titratable intra-operative analgesia delay onset intrathecal morphine . We hypothesise combination might provide desirable intra-operative haemodynamic condition eliminate post-operative additive effect long-acting , intra-operative IV opioid intrathecal morphine . Further , dose intrathecal morphine adequate , would result low rate post-operative analgesic supplementation few side effect . The titratable dose range remifentanil limit low range find risk post-operative hyperalgesia .</detailed_description>
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Morphine</mesh_term>
	<mesh_term>Remifentanil</mesh_term>
	<criteria>Adult ASA I , II stable III Undergoing primary elective hepatic resection &lt; 50 % predict parenchymal resection Previous major upper GI surgery : liver resection transplant gastrectomy oesophagectomy Whipple 's procedure Contraindications dural puncture : coagulopathy uncorrected anticoagulant therapy spinal deformity neurological disorder psychiatric disorder Morphine allergy Comorbidity predisposing failure extubation conclusion surgery : severe cardiopulmonary pathology score ASA III ( unstable ) IV V sleep apnoea morbid obesity ( BMI &gt; 35 ) Failure proceed resection , emergency resection conversion &gt; 50 % parenchymal resection Chronic/intractable pain condition : require longterm high dose analgesia implant analgesic device Predisposition severe postoperative nausea vomiting : motion sickness previous PONV Anatomical physiological indication rapid sequence induction ( relative )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2008</verification_date>
	<keyword>Intrathecal morphine ITM intravenous morphine remifentanil hepatic resection</keyword>
	<keyword>Adult</keyword>
	<keyword>ASA I-III ( stable )</keyword>
	<keyword>Liver dysfunction require primary parenchymal resection</keyword>
</DOC>